Life Insurance Corporation of India

NSE: LICI
NIFTY500
Analyst consensus:Constructive· 24 analysts
₹426.60-5.5%1Y
Last updated 05:04:05 IST· Public market feed (~15 min delay during market hours)

Life Insurance Corporation of India: A 30-second snapshot

LIC of India (LICI) trades at 799.15, a trailing PE of 9.5x and forward PE of 8.0x, reflecting the lowest PE among its assigned peer group of six. Revenue has compounded at 16.1% over five years, yet the stock is 2.0% lower over the past year and sits 6.8% below its 200-DMA of 856.14. Quality score of 49 and consistency score of 66 place it in the middle of the peer pack.

P/E

9.5

Forward P/E

8.0

ROE

Debt / Equity

Profit Margin

+6.0%

Div. Yield

+1.5%

5Y ROE > 15%

4/5

5Y FCF > 0

2/5

Quality

63/100

Recent context

  • ·Life insurers collectively crossed 4 trillion rupees in new business premium in FY26 (Business Standard, April 2026), a sector milestone that positions LICI as the largest participant in an industry at a record volume.
  • ·The Indian government approved 100% foreign investment in the insurance sector (May 2026), a structural policy shift that could alter competitive dynamics for PSU-owned incumbents like LICI.
  • ·LIC deployed approximately $2 billion as a contrarian domestic institutional buyer during a period of broad market weakness (Economic Times, May 2026), reflecting its dual role as both a listed company and a systemic market participant.

Strengths

  • +Lowest PE in the peer group at 9.5x trailing and 8.0x forward, compared with HDFCBANK at 17.2x, BAJFINANCE at 29.8x, and HDFCLIFE at 68.5x — a significant valuation gap relative to sector comparables.
  • +5-year revenue CAGR of 16.1% indicates top-line expansion has been sustained across the measurement window.
  • +Dividend yield of 1.5% provides an income component, consistent with LICI's status as a government-owned enterprise with a regular distribution history.
  • +Mean analyst rating of 1.65 across 24 analysts (1-5 scale, lower = more constructive), with coverage of 24 analysts indicating broad institutional attention for a PSU insurer.

Weaknesses

  • Price has traded below the 200-DMA (856.14) with the current gap at 6.8%; the stock is 17.4% off its 52-week high and down 8.7% over the past three months.
  • ROE data is absent, preventing a full profitability assessment; without it, the quality score of 49 relies on incomplete inputs.
  • FCF was positive in only 2 of the available persistence years, raising questions about the consistency of free cash generation relative to reported earnings.
  • Profit margin of 5.97% is thin for a large-cap insurer; the insurance sector's embedded-value accounting makes headline margins structurally different from non-insurance peers, but the absolute level warrants scrutiny.

Open questions

  • ?Does LICI's structurally lower PE reflect a genuine valuation gap relative to peers, or does the insurer's unique accounting framework (embedded value, participating policyholder funds) make direct PE comparison with banks and holding companies inappropriate?
  • ?How has LICI's new business premium market share trended over the past three years relative to private insurers such as HDFC Life — and does the sector's 100% FDI approval accelerate or moderate that trend?
  • ?Given that FCF was positive in only 2 of the available persistence years, what portion of reported earnings reflects non-cash movements in policyholder reserves versus distributable cash flow?
  • ?How does LICI's role as a large domestic institutional investor interact with its obligations to policyholders — and does that dual role create any alignment or conflict of interest for minority shareholders?

Peer comparison: Banking

Ranks 3 of 6 on quality
SymbolNameP/EROEQuality
LICILife Insurance Corporation of IndiaYou're viewing9.549
Industry avgacross 5 peers31.7+14.2%39
AXISBANKAxis Bank Ltd.14.7+13.2%53
BAJFINANCEBajaj Finance Ltd.29.8+17.9%53
HDFCBANKHDFC Bank Ltd.17.2+13.8%47
BAJAJFINSVBajaj Finserv Ltd.28.4+14.6%23
HDFCLIFEHDFC Life Insurance Company Ltd.68.5+11.3%20

Technical state

Current price

₹799.15

SMA 50

₹795.91

SMA 200

₹856.14

RSI (14)

48.8 (neutral)

From 52w high

-17.4%

1Y return

-2.0%

3M return

-8.7%

50-DMA

Above

200-DMA

Below

Algorithmic support levels

₹796.15
₹788.45
₹721.50

Algorithmic resistance levels

₹815.75
₹856.35
₹863.60

Risk flags

  • medium
    Price at 799.15 is below the 200-DMA (856.14) and has been for an extended period; the stock is down 17.37% from its 52-week high and -2.02% over 12 months, underperforming relative to its 5-year revenue growth of 16.1%.
  • medium
    ROE data is unavailable for LICI, leaving a critical profitability dimension unmeasured. FCF was positive in only 2 of the years available in the persistence record, and profit margin of 5.97% is narrow for a large-cap life insurer.
  • low
    LICI is grouped with banking and diversified-finance peers (HDFCBANK PE 17.2x, BAJFINANCE PE 29.8x, HDFCLIFE PE 68.5x); direct PE comparisons carry limited meaning given the structural differences between a state-owned life insurer and private-sector banks or holding companies.
  • low
    Only 8 news items were captured for this run, of which 3 were negative and 3 neutral; thin coverage limits the reliability of the news sentiment signal.

Cross-section contradictions

  • 5-year revenue CAGR of 16.1% and a forward PE of 8.0x suggest an improving earnings trajectory, yet the stock is down 2.02% over 12 months and trades 6.8% below its 200-DMA — a divergence between reported growth and recent price action.

For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.

Fundamentals & technicals: refreshed 25 Jun 2026 · refreshed daily at 01:00 IST

AI synthesis (narrative, snapshot, strengths/weaknesses, peer ranking): generated 17 May 2026 · rotates through NIFTY 500 every ~5 days